Head-to-head dispatch
CaliberRx vs HealthRX
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
CaliberRx is a 100% online telehealth platform offering compounded GLP-1 weight-loss treatment — semaglutide and tirzepatide — prescribed by licensed clinicians after an online medical-history review.
Marked down on: Pricing is not published — it is shown only after you complete the intake quiz
Desk Score
A LegitScript-certified compounding platform whose pricing page prints every plan's total, per-month rate and renewal price — and whose renewals are cheaper than sign-up.
$190/mo month-to-month ($149 first month on Subscribe & Save, renews at $165) · $99/mo on a 12-month prepay ($1,188) sema · $239/mo month-to-month ($193 first month on Subscribe & Save, renews at $214) · $179/mo on a 12-month prepay ($2,148) tirz · Verified August 29, 2026
Marked down on: Compounded medications are not FDA-approved
HealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 56/100 (C) for CaliberRx. CaliberRx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
CaliberRx
56/100
C
HealthRX
86/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | CaliberRx | HealthRX |
|---|---|---|
| Semaglutide | Not listed on CaliberRx's site (checked June 24, 2026) | $190/mo month-to-month ($149 first month on Subscribe & Save, renews at $165) · $99/mo on a 12-month prepay ($1,188) |
| Tirzepatide | Not listed on CaliberRx's site (checked June 24, 2026) | $239/mo month-to-month ($193 first month on Subscribe & Save, renews at $214) · $179/mo on a 12-month prepay ($2,148) |
| Coverage | Not listed on CaliberRx's site (checked June 24, 2026) | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Shoppers wanting compounded GLP-1 from a compliance-thorough, fully online clinic. | Patients who want a certified program with every plan price and renewal in one table, and a full refund if a provider does not approve them. |
| Desk Score | 56/100C | 86/100B |
The verdict
Desk pick — HealthRXHealthRX takes this head-to-head with the higher Desk Score, 86/100 (B) against 56/100 (C) for CaliberRx. CaliberRx still holds its ground where its strengths line up with yours.
Choose CaliberRx if…
Shoppers wanting compounded GLP-1 from a compliance-thorough, fully online clinic.
Choose HealthRX if…
Patients who want a certified program with every plan price and renewal in one table, and a full refund if a provider does not approve them.
$190/mo month-to-month ($149 first month on Subscribe & Save, renews at $165) · $99/mo on a 12-month prepay ($1,188) sema · $239/mo month-to-month ($193 first month on Subscribe & Save, renews at $214) · $179/mo on a 12-month prepay ($2,148) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: CaliberRx · HealthRX.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: one price at every dose, both molecules, all 50 states — but the $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CaliberRx vs CoreAge Rx
- CoreAge Rx vs HealthRX
- CaliberRx vs Strut Health
- HealthRX vs Trimi
- CaliberRx vs Ondra Health
- Elara Health and Wellness vs HealthRX
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.